NAVLIGAR Trademark

Trademark Overview

On Friday, June 30, 2006, a trademark application was filed for NAVLIGAR with the United States Patent and Trademark Office. The USPTO has given the NAVLIGAR trademark a serial number of 79026617. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, July 1, 2016. This trademark is owned by NOVARTIS AG. The NAVLIGAR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system including diabetes, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in hematology, in oncology, in transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, vaccines, antivirals, antibiotics, and anti-fungals; pharmaceutical preparations treating bacterial-based diseases; pharmaceutical preparations for diagnostic use
navligar

General Information

Serial Number79026617
Word MarkNAVLIGAR
Filing DateFriday, June 30, 2006
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateFriday, July 1, 2016
Registration Number3247826
Registration DateTuesday, May 29, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 13, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system including diabetes, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in hematology, in oncology, in transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, vaccines, antivirals, antibiotics, and anti-fungals; pharmaceutical preparations treating bacterial-based diseases; pharmaceutical preparations for diagnostic use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 3, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events

Event DateEvent Description
Friday, October 13, 2017NOTIFICATION PROCESSED BY IB
Thursday, January 12, 2017NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Thursday, January 12, 2017DEATH OF INTERNATIONAL REGISTRATION
Saturday, June 6, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, April 2, 2015GENERIC MADRID TRANSACTION SENT TO IB
Thursday, April 2, 2015GENERIC MADRID TRANSACTION CREATED
Wednesday, September 3, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, January 3, 2014CANCELLED SECTION 71
Friday, April 12, 2013NEW REPRESENTATIVE AT IB RECEIVED
Saturday, February 23, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, June 19, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 28, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, November 2, 2007FINAL DISPOSITION NOTICE SENT TO IB
Friday, November 2, 2007FINAL DISPOSITION PROCESSED
Thursday, October 25, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 29, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, March 13, 2007PUBLISHED FOR OPPOSITION
Wednesday, February 21, 2007NOTICE OF PUBLICATION
Monday, January 29, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, January 29, 2007ASSIGNED TO LIE
Friday, December 29, 2006REFUSAL PROCESSED BY IB
Tuesday, December 26, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 26, 2006EXAMINER'S AMENDMENT ENTERED
Tuesday, December 26, 2006EXAMINERS AMENDMENT E-MAILED
Tuesday, December 26, 2006EXAMINERS AMENDMENT -WRITTEN
Thursday, December 7, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, December 7, 2006REFUSAL PROCESSED BY MPU
Wednesday, December 6, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, December 5, 2006NON-FINAL ACTION WRITTEN
Saturday, December 2, 2006ASSIGNED TO EXAMINER
Thursday, November 9, 2006ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 9, 2006TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 9, 2006ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 9, 2006TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 8, 2006NEW APPLICATION ENTERED IN TRAM
Thursday, September 7, 2006SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

navligar system preparations pharmaceutical disorders treatment diseases anti prevention infectives vaccines